FORMOSA PHARMACEUTICALS, INC. · 台新藥
Ownership & governance
Executives 5Directors 7Avg tenure 7.9y
LH
Li Ko Hsu
Chief Executive Officer
Since 2017-03-06Profile →
+11
Executives5
Board of directors7
CC
Cheng Yue Cheng→
Chairman
—Since 2010-11-21
WH
Wen Hung Huang→
Director/Board Member
—Since 2017-10-12
HM
Hai Yi Ma→
Director/Board Member
—Since 2017-10-12
HC
Hong Jen Chang→
Director/Board Member
Age 70Since 2020-05-28
YS
Yue Hui Su→
Director/Board Member
—Since 2021-07-08
LL
Li Chu Lo→
Director/Board Member
—Since 2021-07-08
CK
Chao Chou Kang→
Director/Board Member
—Since 2023-05-22
Catalog · 2026-07-09
Registry officers12
| Name | Role | Since | Shares |
|---|---|---|---|
| Cheng Yue Cheng | Chairman | 2010-11-21 | - |
| Li Ko Hsu | Chief Executive Officer | 2017-03-06 | - |
| Nai Hsien Tsao | Director of Finance/CFO | — | - |
| Chao Chou Kang | Director/Board Member | 2023-05-22 | - |
| Hai Yi Ma | Director/Board Member | 2017-10-12 | - |
| Hong Jen Chang | Director/Board Member | 2020-05-28 | - |
| Li Chu Lo | Director/Board Member | 2021-07-08 | - |
| Wen Hung Huang | Director/Board Member | 2017-10-12 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.